Frank J. Palella, MD

Advice to community physicians regarding ways to enhance patient-provider relationships and navigate barriers that impact the management of HIV infections.

Approaches that can help reduce the risk of weight-gain-related cardiometabolic conditions in patients with HIV.

Recommendations for properly assessing patients who are on HIV treatment for signs of potential weight gain.

Adverse events associated with novel treatment regimens used to manage HIV infections, and advice regarding strategies that can be used to monitor for and manage patients.

Patient factors that impact the choice of therapeutic regimen to manage an HIV infection.

Insight surrounding the use of a once daily, single-tablet combination of the protease inhibitor, darunavir, with cobicistat, emtricitabine, and tenofovir in patients with HIV.

Reactions to the FDA approval of bictegravir, emtricitabine, and tenofovir alafenamide as fixed-dose combination therapy for patients with HIV.

The potential role of novel 2-drug regimens as treatment for HIV infections, and variables that impact a physician’s willingness to utilize over standard 3-drug options.

A discussion regarding the risk of weight gain associated with antiretroviral therapies used to treat HIV infections.

The role of antiretroviral therapy and changes in lifestyle in the management of HIV infections.

Best practices for talking with patients about the importance of rapid initiation of therapy for HIV, and other important topics related to their treatment options.

Strategies that can help physicians assess for HIV and talk with patients about concerns regarding quality-of-life issues.